Inhibition of Pancreatic Cancer Cell Viability and Tumor Growth Through Cell Cycle Arrest by an Oral Formulation of Docetaxel DHP23001

Authors :: Jung Hyu Sin
Jae-Jun Lee
Min-Kyoung Kang
Hye Rim Kim
Jung Ae Kang
Sung Hun Kim
Hye Lim Lee
Min-Hee Son
Hye-Jin Park
A-Ram Yu
Source :: International Journal of Pharmacology. 15:994-1000
Publication Year :: 2019
Publisher :: Science Alert, 2019.

Subjects :: Pharmacology
Cell cycle checkpoint
Docetaxel
Pancreatic cancer cell
business.industry
medicine
Cancer research
Tumor growth
business
medicine.drug

Full Text Access

Tools